114 related articles for article (PubMed ID: 25753140)
1. Mycosis fungoides: association of KIR ligands and HLA-DQB1*05 with bad prognosis of the disease.
Brazzelli V; Rivetti N; Badulli C; Carugno A; Cananzi R; De Silvestri A; Martinetti M; Borroni G
J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):266-9. PubMed ID: 25753140
[TBL] [Abstract][Full Text] [Related]
2. Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients.
Brazzelli V; Rivetti N; Badulli C; Carugno A; Grasso V; De Silvestri A; Martinetti M; Borroni G
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1732-7. PubMed ID: 24533560
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma.
Jackow CM; McHam JB; Friss A; Alvear J; Reveille JR; Duvic M
J Invest Dermatol; 1996 Sep; 107(3):373-6. PubMed ID: 8751973
[TBL] [Abstract][Full Text] [Related]
4. Familial mycosis fungoides: report of 6 kindreds and a study of the HLA system.
Hodak E; Klein T; Gabay B; Ben-Amitai D; Bergman R; Gdalevich M; Feinmesser M; Maron L; David M
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):393-402. PubMed ID: 15761416
[TBL] [Abstract][Full Text] [Related]
5. Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients.
Reiter O; Ben Amitai D; Amitay-Laish I; Israeli M; Pavlovsky L; Hodak E
Arch Dermatol Res; 2017 Dec; 309(10):851-856. PubMed ID: 28948342
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
7. The distribution of KIR-HLA functional blocks is different from north to south of Italy.
Fasano ME; Rendine S; Pasi A; Bontadini A; Cosentini E; Carcassi C; Capittini C; Cornacchini G; Espadas de Arias A; Garbarino L; Carella G; Mariotti ML; Mele L; Miotti V; Moscetti A; Nesci S; Ozzella G; Piancatelli D; Porfirio B; Riva MR; Romeo G; Tagliaferri C; Lombardo C; Testi M; Amoroso A; Martinetti M
Tissue Antigens; 2014 Mar; 83(3):168-73. PubMed ID: 24571475
[TBL] [Abstract][Full Text] [Related]
8. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
9. Hypopigmented mycosis fungoides: case reports and literature review.
Qari MS; Li N; Demierre MF
J Cutan Med Surg; 2000 Jul; 4(3):142-8. PubMed ID: 11003719
[TBL] [Abstract][Full Text] [Related]
10. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
[TBL] [Abstract][Full Text] [Related]
11. KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patients.
Shen M; Linn YC; Ren EC
Immunogenetics; 2016 Feb; 68(2):133-44. PubMed ID: 26649563
[TBL] [Abstract][Full Text] [Related]
12. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
[TBL] [Abstract][Full Text] [Related]
13. Possible KIR-driven genetic pressure on the genesis and maintenance of specific HLA-A,B haplotypes as functional genetic blocks.
Capittini C; Tinelli C; Guarene M; Pasi A; Badulli C; Sbarsi I; Garlaschelli F; Cremaschi AL; Pizzochero C; Monti C; Salvaneschi L; Martinetti M
Genes Immun; 2012 Sep; 13(6):452-7. PubMed ID: 22573115
[TBL] [Abstract][Full Text] [Related]
14. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
[TBL] [Abstract][Full Text] [Related]
15. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
16. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
[TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides in childhood: description and study of two siblings.
Vassallo C; Brazzelli V; Cestone E; Castello M; Ciocca O; Borroni RG; Martinetti M; Borroni G
Acta Derm Venereol; 2007; 87(6):529-32. PubMed ID: 17989893
[TBL] [Abstract][Full Text] [Related]
18. Human leucocyte antigen (HLA)-DQB1*03:02 and HLA-A*02:01 have opposite patterns in their effects on susceptibility to HIV infection.
Rallón N; Restrepo C; Vicario JL; Del Romero J; Rodríguez C; García-Samaniego J; García M; Cabello A; Górgolas M; Benito JM
HIV Med; 2017 Sep; 18(8):587-594. PubMed ID: 28218480
[TBL] [Abstract][Full Text] [Related]
19. CD8
Martinez-Escala ME; Kantor RW; Cices A; Zhou XA; Kaplan JB; Pro B; Choi J; Guitart J
J Am Acad Dermatol; 2017 Sep; 77(3):489-496. PubMed ID: 28676328
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.
Pamuk GE; Tozkir H; Uyanik MS; Gurkan H; Duymaz J; Pamuk ON
Leuk Lymphoma; 2015; 56(10):2902-7. PubMed ID: 25699652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
